Valchlor in the Treatment of Lichen Planopilaris

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Lichen Planopilaris
Interventions
DRUG

Mechlorethamine 0.016% Top Gel

Valchlor, a 0.016% gel formulation of mechlorethamine. Once daily application of Valchlor in decreasing disease activity in patients with Lichen Planopilaris.

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Mayo Clinic

OTHER